Toll-like receptors and antimicrobial peptides expressions of psoriasis: correlation with serum vitamin D level.
Kim. Sue Kyung SK; Park. Sun S; Lee. Eun-So ES
Key Findings
- LL‑37 and HBD2 levels are higher in psoriasis skin when serum vitamin D is sufficient
- TLR2 and vitamin D receptor expression are negatively correlated in vitamin‑D‑deficient psoriasis skin but positively correlated when vitamin D is sufficient
- Modulating TLRs, antimicrobial peptides, and vitamin D pathways may offer new ways to treat psoriasis
Practical Outcomes
- Maintaining adequate vitamin D (through sunlight or supplementation) may boost beneficial skin peptides like LL‑37 and help balance immune signaling in psoriasis. Biohackers could consider regular vitamin D testing and supplementation as part of a skin‑health protocol, but specific doses and effects need more research.
Summary
The study found that people with psoriasis who have enough vitamin D in their blood show higher levels of the antimicrobial peptide LL‑37 in their skin, and the relationship between skin immune receptors (TLR2) and vitamin D receptors changes depending on vitamin D status. This hints that keeping vitamin D levels up could influence skin immunity and inflammation.
Abstract
To evaluate the association of Toll-like receptors (TLRs), antimicrobial peptides (AMPs) and vitamin D receptors (VDRs) in psoriasis, lesional (PP) and perilesional skin (PN) from psoriasis, atopic dermatitis (AD) patients and healthy controls (NN) were studied by immunohistochemistry. Compared with PN, AD and NN skin, dysregulated expression of TLRs, AMPs and VDR was detected in PP skin. Noteworthy, our results showed altered correlation between TLR2 and VDR expression in PP and PN skin. Human beta defensin 2 (HBD2) and cathelicidin (LL-37) expressions in the PP skin were higher in serum vitamin D sufficient (VDS) groups than serum vitamin D deficient (VDD) groups. Negative correlation was found between TLR2 and VDR expression in the PP skin of VDD groups. However, positive correlation was noted in the PP skin of VDS groups. Based on the present results, therapies targeting the activity of TLRs, AMPs and vitamin D, including modulation of the TLR-VDR pathways, might provide new therapeutic approaches to the psoriasis and other inflammatory skin diseases.
Study Information
pubmed
2010
2010-09-17T00:00:00.000Z
10.3346/jkms.2010.25.10.1506
32
47